Mark Zuckerberg and Priscilla Chan have joined the $700 million Series C funding round for the Swedish AI-powered preventive healthcare startup Neko Health as individual investors. This investment from the CEO of Facebook parent Meta and his wife comes as the healthcare company prepares to expand into the US. The investment comes ahead of Neko Health’s plans to open its first clinics in New York in 2026.The funding round was led by Lightspeed Venture Partners and O.G. Venture Partners. Zuckerberg and Chan invested in their personal capacity rather than through Meta or a venture fund. Other individual investors participating in the round include Tim Ferriss, Maria Sharapova, Thierry Henry, Jimmy Iovine, will.i.am, Ari Emanuel, Claudia Schiffer, Sir Matthew Vaughn, and Danny Meyer.The latest funding follows Neko Health’s $260 million Series B round announced in January 2025. The company said it has conducted more than 100,000 body scan appointments across the UK and Sweden, while over 350,000 people have either joined its waitlist or signed up for a scan. It also reported a 75% rebooking rate among customers.
Neko Health plans US expansion
Founded by Spotify CEO Daniel Ek and Hjalmar Nilsonne, Neko Health launched its first clinic in Stockholm in 2023. It has since expanded to multiple locations in London, Manchester and Birmingham.The company offers a 60-minute, radiation-free body scan designed to assess skin, blood, heart health and circulation, followed by a same-day review with a clinician. The scan is priced at £299 in the UK and 2,750 Swedish krona (SEK) in Sweden.In June 2026, Neko introduced wearable integration and body composition analysis alongside a new Stockholm clinic equipped with its next-generation Derma-2, Echo-2 and Spectrum-2 scanning systems. The company said these devices will be rolled out across its clinics over time.Neko develops its own scanning hardware, software and clinical protocols. Daniel Ek and Hjalmar Nilsonne have not disclosed how the new funding will be allocated between research and development and the company’s US expansion.Returning institutional investors in the Series C round include Atomico, General Catalyst and Lakestar, while new investors include Liberty City Ventures, Positive Sum and BDT & MSD. Subject to regulatory approval, David Ofer of O.G. Venture Partners will join Neko Health’s board.
Company reports customer uptake
According to the company, three out of four returning members whose scans flagged serious conditions are now healthy or have those conditions under control. Neko also said five of seven key biomarkers improved significantly between members’ first and second scans.Commenting on the funding, Bejul Somaia, global partner at Lightspeed Venture Partners, said, “We believe this is one of the most important healthcare companies of our generation, and we’re proud to deepen our partnership as they continue to reimagine prevention.”Investor Tim Ferriss said, “For more than 20 years, I’ve tracked every metric imaginable to optimise health and performance. It’s expensive, complicated, and fragmented. I’ve invested in Neko because they offer beautiful simplicity, and only simplicity scales: you get a high-definition map of your biology in less than 60 minutes, explained by an unhurried doctor, all in one location and for £299.”Hjalmar Nilsonne added, “This funding is a strong vote of confidence in what we set out to do when we opened our first clinic three years ago: a completely new healthcare experience designed to keep people healthy, catch problems early and help prevent disease before it even starts.”
Leave a Reply